HOME > Clinical Practice > Autoimmune Bullous Diseases

Autoimmune Bullous Diseases (Hideyuki Ujiie, Associate Professor)

It’s been four years since the Special Clinic for Autoimmune Bullous Diseases opened. Dr. Hideyuki Ujiie, Dr. Inkin Ujiie and I see the patients. The numbers of patients have greatly increased since the clinic opened, and we’re able to observe the long-term courses of disorders. In FY2017, we conducted a physician-led therapeutic trial, in cooperation with other facilities, on rituximab as a treatment for intractable pemphigoid. We found this novel treatment to be more effective than steroids, which have been used. Our research focuses on autoimmune subepidermal blistering diseases, particularly on bullous pemphigoid. So, I’d like to thank the doctors of Koshikai and of affiliated hospitals for actively referring patients. We will, of course, make contributions that affect all the readers, such as by providing methods for immunofluorescence studies. We also aim to achieve results for presentation at meetings and to publish papers by reviewing our experience of treating patients and the courses of patients that we’ve accumulated.

Clinical Practice
Clinical Practice top
Hospital Guidance
Patient Information
Clinical Service
Outpatient Clinic
Special Clinic
Genetic Counseling
Skin Tumors and
Laser Therapy
Autoimmune Bullous
Epidermolysis Bullosa
Ichthyosis and Keratoderma
Hospital Word
Inpatient Hospital Ward
For Patients with
Atopic Dermatitis
Surgical Operations